Miragen Therapeutics Inc.
13F holders, Q1 2025 (March 31)2holders
1new positions
1sold out
$0.00avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Miragen Therapeutics Inc. in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were Game Plan Financial Advisors, LLC ($0) and ORG Partners LLC ($0).
- Company
- Miragen Therapeutics Inc.
- CUSIP
- 604CVR019
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 180 shares bought and 500 shares sold, net −320 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Game Plan Financial Advisors, LLC | 0.00% | No change | 7,000 | $0 |
| ORG Partners LLC | 0.00% | New | 180 | $0 |
"% of holder's portfolio" is MIRAGEN THERAPEUTICS INC's weight in each manager's 13F, not the share of Miragen Therapeutics Inc. the manager owns.